UHT - NYSE
Universal Health Realty Income Trust
$40.26
-0.84%Universal Health Realty Income Trust, a real estate investment trust, invests in healthcare and human service related facilities including acute care hospitals, rehabilitation hospitals, sub-acute care facilities, medical/office buildings, free-standing emergency departments and childcare centers. We have investments in seventy-one properties located in twenty states, including two that are currently under construction.
At a Glance
Live SnapshotUniversal Health Realty Income Trust Management Team
Mr. Alan B. Miller
Chairman, President & Chief Executive Officer
Compensation
$29,785
Mr. Robert F. McCadden CPA
Lead Independent Trustee
Compensation
$49,257
Mr. Charles F. Boyle
Senior Vice President & Chief Financial Officer
Compensation
$17,317
Ms. Cheryl K. Ramagano
Senior Vice President of Operations, Treasurer & Secretary
Compensation
$17,317
Ms. Genevieve P. Owsiany
Vice President & Controller
Ms. Karla J. Peterson
Vice President of Acquisitions & Development
Compensation
$8,494
Ms. Judith Klein
Vice President of Asset Management
Universal Health Realty Income Trust Insider Positioning
During the last 12 months, insiders have purchased $453K and sold $14K worth of UHT shares, resulting in $439K of net buying activity.
3 Months
0
0.00
0
0.00
+0
+$0
3-6 Months
0
0.00
0
0.00
+0
+$0
6-9 Months
12.2K
453.40K
0
0.00
+453K
+$453K
9-12 Months
0
0.00
350
14.09K
-14K
-$14K
Top Buyers
Miller Alan B
Director, Officer: President, And Ceo
$453K
Top Sellers
Peterson Karla J
Officer: Vice President
$14K
Insider Activity Analysis
Net Insider Sentiment
Strong bullish signal with $439K net buying. Insiders are aggressively accumulating shares, suggesting significant confidence in future prospects.
Buy/Sell Ratio
Exceptional buy/sell ratio. Buying dramatically outweighs selling—one of the strongest possible insider signals.
Insider Participation
1 insider buyers and 1 sellers. Equal participation suggests mixed or neutral insider views.
SEC Filings
UHT - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
DEF 14A DEF 14A 2026 N/A | April 28, 2026 | June 10, 2026 | 2026 | |
DEF 14A DEF 14A 2025 N/A | April 25, 2025 | June 11, 2025 | 2025 | |
DEF 14A DEF 14A 2024 N/A | April 23, 2024 | June 05, 2024 | 2024 | |
DEF 14A DEF 14A N/A | April 25, 2023 | April 25, 2023 | ||
DEF 14A DEF 14A 2022 N/A | April 26, 2022 | June 08, 2022 | 2022 | |
DEF 14A DEF 14A 2021 N/A | April 20, 2021 | June 02, 2021 | 2021 | |
DEF 14A DEF 14A 2020 N/A | April 21, 2020 | June 03, 2020 | 2020 | |
DEF 14A DEF 14A 2019 N/A | April 25, 2019 | June 12, 2019 | 2019 | |
DEF 14A DEF 14A 2018 N/A | April 26, 2018 | June 13, 2018 | 2018 | |
DEF 14A DEF 14A 2017 N/A | April 20, 2017 | June 07, 2017 | 2017 |
Research Paths
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.